Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Endocrinología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 15 de mar de 2017
ID: NCT03136484
Completado
Fase 3
ClinicalTrials.gov
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 17 de ene de 2017
ID: NCT02692716
Terminado
Fase 2
ClinicalTrials.gov
A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Of The Safety And Efficacy Of PPM-204 In Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de ene de 2007
ID: NCT00425919
Desconocido
ClinicalTrials.gov
Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group
OBSERVATIONAL
Inicio: 22 de nov de 2020
ID: NCT04640064
Terminado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double Blind, Placebo Controlled, Phase II Trial Evaluating the Safety and Efficacy of Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer That Have Evidence of Disease Progression on or After Prior Endocrine Therapy
INTERVENTIONAL
Inicio: 1 de abr de 2012
ID: NCT01528345
Completado
Fase 2
ClinicalTrials.gov
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver
INTERVENTIONAL
Inicio: 1 de mar de 2016
ID: NCT02724540
Completado
ClinicalTrials.gov
Effect of Extra Virgin Olive Oil Addition in the Diet of Women With Gestational Diabetes Mellitus (OLIDIAG)
INTERVENTIONAL
Inicio: 11 de ene de 2022
ID: NCT05120388
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 in Adults With Mixed Dyslipidemia
INTERVENTIONAL
Inicio: 20 de jul de 2022
ID: NCT05256654
Completado
Fase 3
ClinicalTrials.gov
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PHASE III STUDY TO ASSESS THE EFFICACY,SAFETY AND TOLERABILITY OF ALEGLITAZAR ADDED TO A SU OR ADDED TO A SU IN COMBINATION WITH MET IN PATIENTS WITH T2D INADEQUATELY CONTROLLED WITH SU MONOTHERAPY OR WITH SU + METFORMIN COMBINATION THERAPY
INTERVENTIONAL
Inicio: 1 de dic de 2012
ID: NCT01691989
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients With Severe Hypertriglyceridemia
INTERVENTIONAL
Inicio: 31 de ago de 2022
ID: NCT05552326
Completado
Fase 3
ClinicalTrials.gov
A Phase III Multi-Center, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Clinical Trial in High-Risk Type 2 Diabetes Mellitus (T2DM) Subjects With Coronary Artery Disease (CAD) to Determine Whether Bromodomain Extraterminal Domain (BET) Inhibition Treatment With RVX000222 Increases the Time to Major Adverse Cardiovascular Events (MACE)
INTERVENTIONAL
Inicio: 1 de nov de 2015
ID: NCT02586155
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Giredestrant in Combination With Phesgo Versus Phesgo After Induction Therapy With Phesgo + Taxane in Patients With Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally-Advanced or Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 18 de jul de 2022
ID: NCT05296798
Completado
Fase 4
ClinicalTrials.gov
A 26 Week Randomised, Multinational, Open Labelled, 2 Armed, Parallel Group, Treat-to-target Once Daily Treatment Trial With Insulin Detemir Versus Insulin Glargine, Both in Combination With Metformin in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de may de 2009
ID: NCT00909480
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Glyburide Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Sulfonylurea Therapy Alone
INTERVENTIONAL
Inicio: 1 de jul de 2003
ID: NCT00162175
Completado
ClinicalTrials.gov
Effectiveness of a High-risk Diabetic Patients Program
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT01051245
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension
INTERVENTIONAL
Inicio: 22 de ene de 2026
ID: NCT07159841
Terminado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Exubera (Inhaled Insulin) Compared With Subcutaneous Human Insulin Therapy in Adult Subjects With Type 1 Diabetes Mellitus: A Long-Term, Outpatient, Open-Label, Parallel-Group Comparative Trial
INTERVENTIONAL
Inicio: 1 de may de 2002
ID: NCT00137046
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus - Study Two
INTERVENTIONAL
Inicio: 8 de jul de 2015
ID: NCT02460978
Reclutando
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)
INTERVENTIONAL
Inicio: 3 de jun de 2024
ID: NCT06439277
Completado
Fase 2
ClinicalTrials.gov
A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Asses the Safety and Efficacy of Once-Daily KRP-104 in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Alone.
INTERVENTIONAL
Inicio: 1 de oct de 2009
ID: NCT00995345
Anterior
1
...
30
31
32
...
434
Siguiente
Filtros